Konstantinos Sapalidis, Paul Zarogoulidis, Dimitris Petridis, Christoforos Kosmidis, Barbara Fyntanidou, Kosmas Tsakiridis, Elena Maragouli, Aikaterini Amaniti, Dimitris Giannakidis, Charilaos Koulouris, Stylianos Mantalobas, Athanasios Katsaounis, Vyron Alexandrou, Georgios Koimtzis, Efstathios Pavlidis, Anastasios Barmpas, Theodora Tsiouda, Chrysanthi Sardeli, Zoi Aidoni, Haidong Huang, Qiang Li, Wolfgang Hohenforst-Schmidt, Isaak Kesisoglou
Introduction: Lung cancer is diagnosed at advanced stage due to lack of early disease symptoms. Currently we have several different biopsy techniques such as; radial endobronchial ultrasound, convex probe endobronchial ultrasound, electromagnetic navigation, ct guided biospy and transthoracic ultrasound biopsy. Novel therapies such as; immunotherapy is being used for non-small cell lung cancer in the everyday clinical practice as first and second line treatment. Programmed ligand-1 is essential in order to administer immunotherapy as first line treatment...
2019: Journal of Cancer